Pharma Giant AstraZeneca Announced 300 Million Doses of Covid-19 Vaccine Candidate by Year's End
June 5 , 2020
On Thursday, a pharmaceutical company AstraZeneca in United Kingdom announced that it would make 300 million doses of a Covid-19 vaccine candidate from Oxford University scientists by the end of 2020. The UK based pharma giant signed a "landmark" $750 million deal with Vaccine Alliance Gavi and Coalition for Epidemic Preparedness Innovations (CEPI). The foundation CEPI will produce the vaccine while Gavi will lead the procuring efforts. Further, the company also made a licensing deal with India's Serum institute to make 1 billion doses of the vaccine available in India, as well as other developing countries.